Virtu Financial LLC Acquires Shares of 13,356 Senti Biosciences, Inc. (NASDAQ:SNTI)

Virtu Financial LLC bought a new position in Senti Biosciences, Inc. (NASDAQ:SNTI) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 13,356 shares of the company’s stock, valued at approximately $47,000. Virtu Financial LLC owned approximately 0.28% of Senti Biosciences at the end of the most recent reporting period.

Senti Biosciences Trading Down 3.6 %

Shares of SNTI opened at $3.24 on Wednesday. The stock has a 50 day moving average of $3.83 and a 200 day moving average of $3.48. The company has a market capitalization of $84.25 million, a price-to-earnings ratio of -0.21 and a beta of 2.52. Senti Biosciences, Inc. has a 12 month low of $1.52 and a 12 month high of $16.94.

Senti Biosciences (NASDAQ:SNTI) last released its earnings results on Thursday, March 20th. The company reported ($0.67) earnings per share for the quarter, beating analysts’ consensus estimates of ($3.13) by $2.46. The company had revenue of $5.86 million during the quarter, compared to analysts’ expectations of $2.80 million. As a group, equities research analysts predict that Senti Biosciences, Inc. will post -14.54 earnings per share for the current year.

Senti Biosciences Company Profile

Senti Biosciences, Inc operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications.